Impact of high‐dose peginterferon alfa‐2A on virological response rates in patients with hepatitis C genotype 1: A randomized controlled trial
暂无分享,去创建一个
G. Dore | M. Weltman | P. Desmond | G. McCaughan | D. Crawford | S. Roberts | W. Rawlinson | W. Cheng | W. Sievert | P. Marks | B. Rizkalla | J. Depamphilis | Motoko Yoshihara | Paul V. Desmond | Phillipa S. Marks | M. Yoshihara | Jean K. DePamphilis | Phillipa S. Marks